Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Pharmacol. 2006 Aug;6(4):379-86. Epub 2006 May 18.

Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response.

Author information

  • 1Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN 38105, USA. peter.murray@stjude.org

Abstract

Interleukin (IL)-10 performs an irreplaceable role in negatively regulating inflammation, primarily through a mechanism that selectively blocks the expression of pro-inflammatory genes encoding cytokines, chemokines, cell-surface molecules and other molecules involved in the propagation of inflammation. Not surprisingly, IL-10 has attracted interest as a tool to regulate inflammatory diseases. The clinical use of IL-10 as an anti-inflammatory agent has, however, not met expectations. Nevertheless, the signaling pathway used by the IL-10 receptor to generate the anti-inflammatory response is only beginning to be understood and could be a way to regulate inflammation by pharmacological agents.

PMID:
16713356
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk